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Abstract
Chlamydia trachomatis (C. trachomatis) is an intracellular obligate bac-
terium. It is the most common cause of pelvic inflammatory disease 
(PID) amongst a spectrum of diseases. Chlamydia infection is of a ma-
jor public health concern especially in developing countries. It is esti-
mated that about 600 million people are infected worldwide annually 
yet its roles in the pathogenesis of gynecological cancers are poorly 
understood and has not been fully elucidated. An understanding of 
the mechanisms underlying cancer development following PID due to 
C. trachomatis will be essential in prevention and providing more ra-
tional treatments. This review discusses the mechanisms and sequence 
of events linking Chlamydial infections to carcinogenesis in the female 
reproductive organs. Possible links between C. trachomatis infection 
and cancer development in the female reproductive organs are pro-
posed. C. trachomatis infection as a co factor is also re-examined in 
light of these possible mechanisms.
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Introduction
Chlamydia trachomatis (C. trachomatis) is an intracellular obligate 
gram-negative bacterium. It exists in two forms, alternating between 
elementary body (EB) that is metabolically inactive but highly infectious 
and reticulate body that is metabolically active and involved in its repli-
cation. C. trachomatis depends on its host for energy, metabolism and 
reproduction (as reviewed by Ajonuma et al.) [1]. Chlamydia infection 
is of a major public health concern and it is estimated that about 600 
million people are infected worldwide annually [2]. C. trachomatis 
infect epithelia of many organs leading to a spectrum of pathological 
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conditions such as cervicitis, endometritis, salpingitis 
epidydimitis, prostatitis, lymphangitis, pneumonitis, 
conjunctivitis, keratitis and trachoma the main cau-
se of preventable blindness [1]. Different serovars 
do have tropisms for different epithelia and tissues. 
Serovars A to C infects the eye, while serovars D to 
K the genitourinary tract [3]. Majority of the cases 
are sub-acute leading to persistence and /or chro-
nic infection, which elicits immune response, tissue 
scaring, damage and other cascade of events such 
as epithelial transformation.
However, there is little information in the literature 
regarding the mechanisms of C. trachomatis infec-
tion in the pathogenesis of gynecological cancers. 
This review proposes the possible links between C. 
trachomatis in pelvic inflammatory disease and the 
subsequent gynecological cancers. The roles of C. 
trachomatis as a cofactor in the pathogenesis of 
gynecological cancers are examined in light of these 
mechanisms. New research on elucidating the invol-
vement of C. trachomatis in gynecological cancers 
is suggested.
Results
Chlamydial infection of the Pelvic organs
C. trachomatis infection is the most common se-
xually transmitted bacterial infection worldwide [4] 
and the leading cause of pelvic inflammatory disea-
se (PID) [5, 6]. There is evidence that about 20% of 
women with chlamydial lower genital tract infection 
develop PID [7] while Jones et al. reported that 41% 
of women with C. trachomatis infection had endo-
metrial infections [8]. Endometritis due to C. tra-
chomatis has also been reported [9-12]. C. tracho-
matis was recovered from uteri and Fallopian tubes 
of women with acute salpingitis [11] and its DNA 
detected in women with post-infectious infertility 
[13, 14]. Serological studies on women who had 
salpingitis demonstrated strong association of tubal 
factor related infertility with previous C. trachomatis 
infection [8]. There is increased prevalence of spon-
taneous abortion in women who had chlamydial 
salpingitis [15] or had been previously exposed to C. 
trachomatis [16]. Interestingly, most C. trachomatis 
infections are sub-acute, leading to persistent and /
or chronic infections, eliciting immune response.
Heat shock proteins (HSP) are increased in women 
with previous chlamydial infections [17]. Persistent 
infection through constant exposure to C. tracho-
matis leads to production of HSP that elicits inten-
se immune and inflammatory reactions, leading to 
tissue scarring and endometrial and Fallopian tube 
damage. HSP 10 is associated with tubal factor in-
fertility in a C. trachomatis exposed population [18] 
and HSP 57 with elementary and reticulate bodies 
showed delayed hypersensitivity response [17]. HSP 
60 is capable of eliciting intense mononuclear in-
flammation and elaboration of inflammatory cyto-
kines [14, 19]. Chlamydial HSP may function in at 
least two different ways to promote chronic disease. 
Firstly, through direct antigenic stimulation and se-
condly as signal transducers that result in macropha-
ge activation [19].
Despite C. trachomatis being recognized for long 
as the most important cause of chronic PID world-
wide, the sequence of events linking Chlamydial in-
fections to carcinogenesis in the female reproducti-
ve organs has not been elucidated to a satisfactory 
extent.
Pathogenesis of Chlamydial infections in 
carcinogenesis 
Chronic and or persistent bacterial infections have 
been implicated in the occurrence of cancer [20]. 
Several studies have associated chlamydial infection 
with the development of cervical [21, 22] and ova-
rian [23] carcinoma.
Chlamydia can establish asymptomatic, persistent 
infections by several mechanisms, including antibio-
tic resistance, immune evasion, and apoptosis sup-
pression [24]. C. trachomatis triggers activation of 
oncogenic Ras-Raf-MEK-ERK pathway components 
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[25, 26] and production of reactive oxygen species 
(ROS) to support its growth [27].
It has been reported in various human and other 
mammalian cell lines that Chlamydia infection can 
lead to significant increases in host cell multinuclea-
tion [28], a condition well linked to tumorigenesis 
[29, 30].
Bacterial pathogens are known to modify the 
chromatin architecture of host cells, thus mani-
pulating host transcriptomes, such as to suppress 
immune responses [31]. C. pneumoniae induces 
modifications of histones H3 and H4, which plays 
an important role in cytokine production [32]. Re-
cently, it has been reported that chlamydial nuclear 
effector protein (Nue) has histone methyltransfera-
se activity that targets histones H2B, H3, and H4 
[33]. Chromatin alterations, such as histone modi-
fications, may induce somatically heritable changes 
of gene activity and thus have oncogenic potential 
[34]. Collectively, these data establish that bacterial 
pathogens induce multiple types of histone PTMs, 
although the mechanisms and extent of this phe-
nomenon requires elucidation.
Chlamydia trachomatis infection causes mitotic 
spindle pole defects [35] and resists apoptosis in-
duction in actively dividing cells [36, 37] leading to 
cell transformation and carcinogenesis.
Chlamydia infection has been reported to increa-
se supernumerary centrosomes, abnormal spindle 
poles, and chromosomal segregation defects [38], 
centrosome amplification and multipolar spindle 
formation that may lead to chromosomal instability. 
Inappropriate activation of ERK and elevated global 
heterochromatin is a hallmark of many cancers [39, 
40].
It has been reported that Chlamydial infection 
alters the transcription of host cell genes including 
those for cell differentiation, transcription factors 
and inhibition of apoptosis [41]. It has also been de-
monstrated that C. trachomatis infection results in 
increased tyrosine phosphorylation of several host 
proteins including those involved in signal transduc-
tion pathways [41, 42, 43, 44]. During Chlamydial 
infection, bacteria binding may stimulate receptor 
signaling leading to protein tyrosine phosphoryla-
tion. 
Recently, the role of chromatin and histone mo-
difications in promoting DNA damage responses 
(DDRs) and genome stability have gained promi-
nence [45]. Upon detection of DNA double-strand 
breaks (DSBs), cells activate DDR pathways that 
detect DNA lesions and signal their presence by 
mediating responses such as cell-cycle arrest, DNA 
repair, and, under some circumstances, apoptosis. 
Phosphorylation of H2AX Ser139 (γH2AX) is a pro-
minent chromatin modification in response to DSBs 
that acts as a signal for recruitment of repair prote-
ins including pATM and 53BP1 to DNA break sites. 
Deficiencies in DNA damage signaling and repair 
pathways lead to genetic instability, which in turn 
might enhance oncogenesis [46].
Deficiencies in DNA damage signaling and re-
pair pathways lead to genetic instability, which 
in turn might enhance oncogenesis [46]. Chro-
matin alterations, such as histone modifications, 
may induce somatically heritable changes of gene 
activity and thus have oncogenic potential [34]. 
Histone posttranslational modifications (PTMs) are 
typically induced by signal transduction pathways 
activated in response to cellular stimuli. One pro-
minent pathway implicated in histone PTMs is the 
mitogen-activated protein kinase (MAPK) cascade, 
which leads to histone H3 serine 10 (H3S10) phos-
phorylation in a promoter-specific manner, targe-
ting only a subset of genes [47]. Bacterial patho-
gens such as Mycobacteria, Shigella, Listeria, and 
Helicobacter are known to modify the chromatin 
architecture of host cells, thus manipulating host 
transcriptomes, e.g., to suppress immune respon-
ses [31]. Furthermore, C. pneumoniae induces mo-
difications of histones H3 and H4, which play an 
important role in cytokine production [32]. More 
recently, the chlamydial nuclear effector protein 
(Nue) was shown to have histone methyltransfera-
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se activity that targets histones H2B, H3, and H4 
[33]. Collectively, these data establish that bacterial 
pathogens induce multiple types of histone PTMs, 
although the mechanisms and extent of this phe-
nomenon requires elucidation.
Furthermore, Chlamydia infection has been 
shown to increase supernumerary centrosomes, 
abnormal spindle poles, and chromosomal segre-
gation defects [38]. Inappropriate activation of ERK 
and elevated global heterochromatin is a hallmark 
of many cancers [39, 40].
Chlamydiae produce a unique family of T3SS 
effectors termed inclusion membrane proteins 
(Incs) [48, 49]. These effectors are translocated 
across, and inserted into, the inclusion membra-
ne, in which they are ideally positioned to mediate 
host-pathogen interactions [50]. They have hydro-
phobic domains composed of two closely spaced 
membrane-spanning regions that are separated 
by a short hairpin loop, with their amino termi-
nus and/or carboxyl terminus predicted to extend 
into the cytoplasm of the host cell [51]. Incs are 
primarily expressed early during infection, when 
they may be important in the establishment of 
the inclusion, and at mid-cycle, when they may 
be involved in the maintenance of the inclusion 
and the acquisition of nutrients [50]. Genome-wi-
de comparisons reveal a core set of Incs that are 
shared across Chlamydia spp. as well as diverse 
species-specific Incs that may be key determinants 
of host tropism and site-specific disease [48, 49]. 
Incs share little homology to each other or to other 
known proteins, with the exception of coiled-coil 
or soluble N-ethylmaleimide-sensitive factor atta-
chment protein receptor (SNARE)-like domains, 
which provides limited insight into their functions 
[51]. Incs are hypothesized to recruit host proteins 
to the inclusion membrane to promote fusion with 
nutrient-rich compartments, inhibit fusion with de-
gradative compartments, hijack host machinery or 
organelles, disrupt normal host pathways, or as-
semble novel complexes with new functions [50]. 
The Inc-host interactions identified thus far indica-
te that Incs participate in numerous processes, in-
cluding the rearrangement of the host cell cytoske-
leton, membrane dynamics, centrosome tethering, 
lipid acquisition and resistance to apoptosis [50]. 
In addition, Incs form homotypic or heterotypic 
complexes on the surface of the inclusion [52, 53]. 
Finally, Incs may provide structural stability to the 
growing inclusion membrane [54]. A large-scale 
proteomic screen of Incs in C. trachomatis has re-
vealed putative host binding partners for approxi-
mately two-thirds of Incs [55]. All these complex 
formations and cytoskeleton rearrangements may 
lead to host cell tissue transformation. C. tracho-
matis infection also shown to upregulate the ex-
pression of cystic fibrosis transmembrane regula-
tor (CFTR) gene in reproductive organs [56] and 
in hydrosalpinx [57] induced epithelial transforma-
tion to pseudostratification and focally attenuated 
epithelium. These epithelial transformations may 
irreversibly progress to cancer. Figure 1 shows the 
proposed sequence of events linking C. trachoma-
tis infection to increased chromosomal instability 
and then gynecological cancers. 
C. trachomatis as a co-factor in 
carncinogenesis
Although human papilloma virus (HPV) is known 
to cause cervical cancer, there is some evidence 
that C. trachomatis may also act as a co-factor [58]. 
Chlamydial infections have been epidemiologica-
lly linked to cervical cancer in women co-infected 
with the HPV [59] and when several studies from 
different countries were pooled 60]. Studies have 
also shown that C. trachomatis infection confers 
an increased risk of squamous cell carcinoma, after 
adjusting for HPV infection, smoking, and depen-
ding on the serotype involved [61-65]. Some C. 
trachomatis serotypes B, D, E, G, I, and J have 
been found to increase the risk of squamous cell 
cancer [66, 67], while serotypes C, F, H, and K 
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have not. How C. trachomatis exactly enhance on-
cogenesis as a co factor to HPV infection is not 
fully understood but it has been suggested to be 
due to chronic inflammation and metaplasia [68]. 
Other mechanisms have also been proposed. C. 
trachomatis may promote the persistence of HPV 
infection [69, 70]. HPV can remain latent for years 
after infection. In the presence of C. trachomatis, 
HPV high risk oncogens E6 and E7 may undergo 
activation leading to chromosomal abnormalities 
and immortalization. 
 In vitro infection of fibroblasts and cervical tis-
sue that were free of HPV showed decreased ex-
pression of the tumor suppressor gene caveolin-1 
and increased expression of the proto-oncogene 
c-myc, indicating there may be other possible 
ways that C. trachomatis may promote oncoge-
nesis [71]. Since C. trachomatis infection can in-
duce centrosome abnormalities, spindle effects, 
and chromosome segregation errors leading to 
cell transformation, the presence of these defects 
within infected actively dividing cells is a possible 
mechanism for C. trachomatis as a co factor in 
cancer formation. Figure 2 shows the proposed 
possible sequence of events linking C. trachoma-
tis infection to increased chromosomal instability, 
epithelial cell differentiation and immortalization 
in the presence of HPV.
Figure 1.
A schematic illustration of proposed mechanisms and sequence of events linking C. trachomatis infection and cancer development in the female reproductive 
organs. C. trachomatis infection results in the production of Heat Shock Proteins (HSP), histone chromatin alterations and chronic and or persistent infection. This 
leads to increased expression of oncogens and suppression of apoptosis induction. As well as tyrosine phosphorylation of genes, centrosome amplification, spindle 
formation and delayed DNA damage response. All these lead to increased chromosomal instability, cell differentiation and cancer formation. 
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Conclusions
In summary, chronic and persistent inflammation 
of the female reproductive organs epithelia fo-
llowing chlamydial infections leads to subsequent 
tissue transformation, causes mitotic spindle pole 
defects, alters the transcription of host cell genes, 
decreased expression of the tumor suppressor ge-
nes, increased tyrosine phosphorylation of several 
host proteins including those involved in signal 
transduction pathways, increased expression of the 
proto-oncogens like c-myc, leading to delayed DNA 
damage response and chromosomal instability then 
promoting oncogenesis. New research focusing on 
the above mentioned pathways may provide crucial 
information for a better understanding on the role 
of C. trachomatis infection in pathogenesis of gy-
necological cancers. 
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Figure 2.
A schematic illustration of proposed mechanisms and sequence of events linking C. trachomatis infection and cancer development in the female reproductive 
organs. C. trachomatis infection results in the production of Heat Shock Proteins (HSP), histone chromatin alterations and chronic and or persistent infection. This 
leads to increased expression of oncogens and suppression of apoptosis induction. As well as tyrosine phosphorylation of genes, centrosome amplification, spindle 
formation and delayed DNA damage response. All these lead to increased chromosomal instability, cell differentiation and cancer formation. 
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